Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
about
Multisciplinary management of patients with liver metastasis from colorectal cancerMultidisciplinary approach of colorectal cancer liver metastases.Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.The state of regional therapy in the management of metastatic colorectal cancer to the liver.Other non-surgical treatments for liver cancer.DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease.Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes.Hepatic Arterial Therapy for First-Line Treatment of Unresectable Colorectal Liver Metastases: What We Know in the Wake of Two Recent Randomized Control Trials.Liver-directed therapy in metastatic colorectal cancer.The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer
P2860
Q28069575-6C324931-8964-41F2-8376-47347096B373Q33779859-C6149BED-9253-42B9-8525-C90F32724535Q33889370-A19EE586-43A7-4FF4-B1DB-347EE54096DDQ36392298-DBF8D27A-FC5A-43AF-8D6E-E3500B8B6008Q38664762-4E7CACB8-C337-4EF1-81E2-F22EB51D3D34Q38685463-2A7FEED7-79B9-4634-93D8-8B0452DEB462Q38691238-0BFAEEDE-3342-4F1A-BD69-41A5C59FFF06Q38779462-48292239-A993-4D17-8010-230701A4EFFBQ39025257-B345B8F0-EFD3-40A8-8E2A-71067BBA893AQ41015601-5158E06A-9515-40B9-9BC7-A767A3579D26Q47321056-97134733-BD06-4D8D-AD0E-3A2ED925BD30Q48344683-620C8E90-CA69-4910-AC09-EAE56D7F41DCQ51842624-F8EED670-B53C-4C85-93EC-FE8C9B5F3A0AQ57193222-1242657F-1707-4CB6-ACF9-87B29DA1BDB7
P2860
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Randomized controlled trial of ...... ctal liver-limited metastasis.
@en
Randomized controlled trial of ...... ctal liver-limited metastasis.
@nl
type
label
Randomized controlled trial of ...... ctal liver-limited metastasis.
@en
Randomized controlled trial of ...... ctal liver-limited metastasis.
@nl
prefLabel
Randomized controlled trial of ...... ctal liver-limited metastasis.
@en
Randomized controlled trial of ...... ctal liver-limited metastasis.
@nl
P2093
P2860
P356
P1433
P1476
Randomized controlled trial of ...... ectal liver-limited metastasis
@en
P2093
Charles R Scoggins
Christopher J Laing
Clifton M Tatum
Lawrence R Kelly
Marshall Schreeder
Robert C G Martin
Steven M Strasberg
Todd S Crocenzi
Vivek R Sharma
William S Rilling
P2860
P304
P356
10.1002/CNCR.29534
P407
P577
2015-07-06T00:00:00Z